Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Prof. Angelo Di Leo will be presented with the ESMO Lifetime Achievement Award during the Opening Ceremony of the ESMO Congress taking place in Barcelona, 27 September - 1 October.
This year’s ESMO Women for Oncology Award goes to Cristiana Sessa, who will receive the distinction at the ESMO Congress 2019 taking place in Barcelona from 27 September to 1 October
Prof. Charles Swanton is the winner of this year’s ESMO Translational Research Award, which will be presented to him at the upcoming ESMO Congress 2019 in Barcelona.
Participants from all over the world are expected in Barcelona, Spain, between 24 September and 1 October to attend the leading international oncology event in Europe, the ESMO Congress 2019.
Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in patients with metastatic colorectal cancer who have ceased to respond to standard therapy (known as refractory mCRC)
New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer.
Stomach cancer should no longer be considered a disease only of older people, and patients under 40 with chronic digestive symptoms should be more actively investigated – especially if they are of Latin American ethnicity.
Around 3,500 oncology professionals and researchers from around the world will learn about the latest advances in the field at the 21st ESMO World Congress on Gastrointestinal Cancer taking place in Barcelona, Spain, from 3 to 6 July 2019.
An international group of researchers has found that antibodies to the human papilloma virus type 16 develop in the body between six to 40 years prior to a clinical diagnosis of throat cancer, and their presence indicates a strong increased risk of the disease.
ESMO, the leading European professional organisation for medical oncology, has announced that the ESMO Congress 2021 will take place from 17 to 21 September 2021 at the Paris Expo Porte de Versailles, France.
De-escalation approaches in the treatment of women with HER2 positive breast cancer need to be personalised
Breast cancer in young women is characterised by more aggressive biological features as compared to those arising in older patients
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
